Zivo Bioscience Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $18.91 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Zivo Bioscience Inc had its IPO on 2012-09-24 under the ticker symbol ZIVO.
The company operates in the Healthcare sector and Biotechnology industry. Zivo Bioscience Inc has a staff strength of 8 employees.
Shares of Zivo Bioscience Inc opened at $1.8 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.7 - $1.85, and closed at $1.72.
This is a -4.97% slip from the previous day's closing price.
A total volume of 10,560 shares were traded at the close of the day’s session.
In the last one week, shares of Zivo Bioscience Inc have slipped by -8.99%.
Zivo Bioscience Inc's Key Ratios
Zivo Bioscience Inc has a market cap of $18.91 million, indicating a price to book ratio of 17.8599 and a price to sales ratio of 2639.1661.
In the last 12-months Zivo Bioscience Inc’s revenue was $4050 with a gross profit of $20000 and an EBITDA of $0. The EBITDA ratio measures Zivo Bioscience Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Zivo Bioscience Inc’s operating margin was -208195% while its return on assets stood at -160.3% with a return of equity of -611.37%.
In Q2, Zivo Bioscience Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Zivo Bioscience Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.91 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zivo Bioscience Inc’s profitability.
Zivo Bioscience Inc stock is trading at a EV to sales ratio of 3047.7572 and a EV to EBITDA ratio of -2.5029. Its price to sales ratio in the trailing 12-months stood at 2639.1661.
Zivo Bioscience Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- Total Liabilities
- $3.80 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Zivo Bioscience Inc ended 2023 with $710330.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $710330.00 while shareholder equity stood at $-3144832.00.
Zivo Bioscience Inc ended 2023 with $0 in deferred long-term liabilities, $3.80 million in other current liabilities, 9420.00 in common stock, $-119848244.00 in retained earnings and $0 in goodwill. Its cash balance stood at $21067.00 and cash and short-term investments were $21067.00. The company’s total short-term debt was $1,458,452 while long-term debt stood at $0.
Zivo Bioscience Inc’s total current assets stands at $530075.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $2956.00 compared to accounts payable of $1.27 million and inventory worth $0.
In 2023, Zivo Bioscience Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Zivo Bioscience Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Zivo Bioscience Inc stock is currently trading at $1.72 per share. It touched a 52-week high of $3.75 and a 52-week low of $3.75. Analysts tracking the stock have a 12-month average target price of $6.
Its 50-day moving average was $1.98 and 200-day moving average was $2.69 The short ratio stood at 6.88 indicating a short percent outstanding of 0%.
Around 2523.9% of the company’s stock are held by insiders while 444.7% are held by institutions.
Frequently Asked Questions About Zivo Bioscience Inc
Similar Industry Stocks (Biotechnology)
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.